Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Treatment with docetaxel and cisplatin in advanced adrenocortical carcinoma, a phase II study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Intratumor heterogeneity of PD-L1 expression in head and neck squamous cell carcinoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Risk of cardiovascular events in men treated for prostate cancer compared with prostate cancer-free men

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Behandling af tymom og thymuskarcinom

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prognostic factors for relapse in patients with clinical stage I testicular cancer: Protocol for a Danish nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Adrenocortical carcinoma (ACC) is a rare disease with a poor response to chemotherapy. Cisplatin is the most widely investigated drug in the treatment of ACC and in vitro studies have indicated activity of taxanes. The objectives of this study were to evaluate the efficacy and toxicity of cisplatin combined with docetaxel as first-line treatment of advanced ACC.
Original languageEnglish
JournalB J C
Volume108
Issue number10
Pages (from-to)1994-7
Number of pages4
ISSN0007-0920
DOIs
Publication statusPublished - 28 May 2013

    Research areas

  • Adrenal Cortex Neoplasms, Adrenocortical Carcinoma, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Cisplatin, Disease Progression, Female, Humans, Male, Middle Aged, Survival Analysis, Taxoids, Treatment Outcome, Young Adult

ID: 42241587